G

Grand Pharmaceutical Group Ltd
HKEX:512

Watchlist Manager
Grand Pharmaceutical Group Ltd
HKEX:512
Watchlist
Price: 5.6 HKD -3.45%
Market Cap: 19.9B HKD

Intrinsic Value

The intrinsic value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is 3.95 HKD. Compared to the current market price of 5.6 HKD, Grand Pharmaceutical Group Ltd is Overvalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
3.95 HKD
Overvaluation 30%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
Grand Pharmaceutical Group Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Grand Pharmaceutical Group Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Grand Pharmaceutical Group Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Grand Pharmaceutical Group Ltd
HKEX:512
HK
Pharmaceuticals
Market Cap
19.6B HKD
IPO
Dec 19, 1995
HK
Pharmaceuticals
Market Cap
19.6B HKD
IPO
Dec 19, 1995
Price
HK$false
EPS
HK$false
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Grand Pharmaceutical Group Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Grand Pharmaceutical Group Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Grand Pharmaceutical Group Ltd

Current Assets 8B
Cash & Short-Term Investments 2.8B
Receivables 3.3B
Other Current Assets 2B
Non-Current Assets 17B
Long-Term Investments 8.2B
PP&E 4.3B
Intangibles 3.4B
Other Non-Current Assets 1.1B
Efficiency

Free Cash Flow Analysis
Grand Pharmaceutical Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Grand Pharmaceutical Group Ltd

Revenue
11.6B HKD
Cost of Revenue
-4.9B HKD
Gross Profit
6.7B HKD
Operating Expenses
-4.5B HKD
Operating Income
2.2B HKD
Other Expenses
248.9m HKD
Net Income
2.5B HKD
Fundamental Scores

Profitability Score
Profitability Due Diligence

Grand Pharmaceutical Group Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive Net Income
61/100
Profitability
Score

Grand Pharmaceutical Group Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Grand Pharmaceutical Group Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Negative Net Debt
High Interest Coverage
67/100
Solvency
Score

Grand Pharmaceutical Group Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Grand Pharmaceutical Group Ltd

Wall Street analysts forecast Grand Pharmaceutical Group Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Grand Pharmaceutical Group Ltd is 6.83 HKD with a low forecast of 6.26 HKD and a high forecast of 7.56 HKD.

Lowest
Price Target
6.26 HKD
12% Upside
Average
Price Target
6.83 HKD
22% Upside
Highest
Price Target
7.56 HKD
35% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Grand Pharmaceutical Group Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Grand Pharmaceutical Group Ltd stock?

The intrinsic value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is 3.95 HKD.

Is Grand Pharmaceutical Group Ltd stock undervalued or overvalued?

Compared to the current market price of 5.6 HKD, Grand Pharmaceutical Group Ltd is Overvalued by 30%.

Back to Top